SCOZZAFAVA, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 44.084
EU - Europa 14.572
AS - Asia 3.504
OC - Oceania 381
AF - Africa 217
Continente sconosciuto - Info sul continente non disponibili 16
SA - Sud America 10
Totale 62.784
Nazione #
US - Stati Uniti d'America 44.002
RU - Federazione Russa 4.530
SE - Svezia 2.230
PL - Polonia 2.229
IE - Irlanda 1.965
IT - Italia 1.237
SG - Singapore 1.094
HK - Hong Kong 1.093
FI - Finlandia 646
DE - Germania 606
UA - Ucraina 457
GB - Regno Unito 434
IN - India 423
TR - Turchia 377
AU - Australia 376
CN - Cina 243
CI - Costa d'Avorio 198
JO - Giordania 113
CA - Canada 82
VN - Vietnam 80
CH - Svizzera 49
BE - Belgio 44
KR - Corea 43
NL - Olanda 40
FR - Francia 38
ES - Italia 28
ID - Indonesia 22
EU - Europa 16
SC - Seychelles 14
AT - Austria 10
BR - Brasile 7
LT - Lituania 7
RO - Romania 7
BG - Bulgaria 6
JP - Giappone 6
NZ - Nuova Zelanda 5
IR - Iran 4
DK - Danimarca 3
AR - Argentina 2
CZ - Repubblica Ceca 2
MU - Mauritius 2
PK - Pakistan 2
TW - Taiwan 2
AZ - Azerbaigian 1
BY - Bielorussia 1
CO - Colombia 1
EG - Egitto 1
GR - Grecia 1
LV - Lettonia 1
NG - Nigeria 1
PT - Portogallo 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 62.784
Città #
Fairfield 7.911
Santa Clara 5.597
Woodbridge 3.616
Seattle 3.271
Ashburn 3.190
Cambridge 3.075
Houston 2.826
Wilmington 2.509
Warsaw 2.224
Chandler 2.076
Dublin 1.963
Jacksonville 1.161
Ann Arbor 1.067
Lawrence 863
Singapore 847
Altamura 733
Princeton 639
Boardman 483
Medford 396
Hong Kong 393
Melbourne 373
Boston 333
Izmir 301
San Diego 301
Mumbai 273
Abidjan 198
Florence 147
Norwalk 126
Moscow 122
Beijing 83
Falls Church 77
Buffalo 71
Andover 70
Hillsboro 65
Dong Ket 64
Dearborn 62
Toronto 60
Shanghai 49
Bern 48
Los Angeles 45
Brussels 44
Düsseldorf 44
London 43
Milan 43
Helsinki 42
New York 42
Kent 36
Yubileyny 32
Auburn Hills 26
Barcelona 25
Tappahannock 23
Jakarta 22
Laurel 22
Phoenix 19
Redmond 16
Romola 16
Salerno 16
Frankfurt Am Main 15
Chiswick 14
West Jordan 14
Kilburn 12
Bremen 11
Grevenbroich 11
Redwood City 11
San Mateo 11
Prescot 10
Verona 10
Vienna 10
Hounslow 9
Rome 9
Gavirate 8
Old Bridge 8
Seoul 8
Detroit 7
Seongnam 7
Yaroslavl 7
Guangzhou 6
Leawood 6
Montréal 6
Napoli 6
New Bedfont 6
Scandicci 6
Siena 6
Timisoara 6
Trumbull 6
Washington 6
Arnsberg 5
Chicago 5
Incisa 5
Naaldwijk 5
Sofia 5
Southwark 5
Abbotsford 4
Ardea 4
Bari 4
Fort Worth 4
Jinan 4
Naples 4
Ottawa 4
Saint-Fons 4
Totale 48.533
Nome #
A 31P NMR study of phosphate in presence of cobalt(II)- and copper(II)- substituted bovine carbonic anhydrase B. 318
Biotransformation of Chloroaromatics: the Impact of Bioavailability and Substrate Specificity. 300
Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. 277
Glycosyl Coumarin Carbonic Anhydrase IX and XII Inhibitors Strongly Attenuate the Growth of Primary Breast Tumors. 264
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule. 263
Characterization of the first beta-class carbonic anhydrase from an arthropod (Drosophila melanogaster) and phylogenetic analysis of beta-class carbonic anhydrases in invertebrates. 260
Ureido-Substituted Benzenesulfonamides Potently Inhibit Carbonic Anhydrase IX and Show Antimetastatic Activity in a Model of Breast Cancer Metastasis 248
Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis 245
Assembly comprising an absorber of near infrared (nir) light covalently linked to an inhibitor of carbonic anhydrase 245
Carbonic anhydrase inhibitor coated gold nanoparticles selectively inhibit the tumor-associated isoform IX over the cytosolic isozymes I and II. 245
Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations. 238
Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. 230
Carbonic Anhydrase Activators: Gold Nanoparticles Coated with Derivatized Histamine, Histidine, and Carnosine Show Enhanced Activatory Effects on Several Mammalian Isoforms. 229
Crystal structure of a blue laccase from Lentinus tigrinus: evidences for intermediates in the molecular oxygen reductive splitting by multicopper oxidases. 229
Mono-/dihydroxybenzoic acid esters and phenol pyridinium derivatives as inhibitors of the mammalian carbonic anhydrase isoforms I, II, VII, IX, XII and XIV. 213
Biodegradation of 2-naphthalensulfonic acid polymers by white-rot fungi: Scale-up into non-sterile packed bed bioreactors 193
Inhibition of the β-carbonic anhydrase from Streptococcus pneumoniae by inorganic anions and small molecules: Toward innovative drug design of antiinfectives? 193
Dithiocarbamates with potent inhibitory activity against the Saccharomyces cerevisiae β-carbonic anhydrase 184
Novel small molecule protein arginine deiminase 4 (PAD4) inhibitors 174
Structural modulation of the biological activity of gold nanoparticles functionalized with a carbonic anhydrase inhibitor. 165
Next-generation polyamine human carbonic anhydrase inhibitors 165
Structural effect of phenyl ring compared to thiadiazole based adamantyl-sulfonamides on carbonic anhydrase inhibition 165
1,3-Oxazole-based selective picomolar inhibitors of cytosolic human carbonic anhydrase II alleviate ocular hypertension in rabbits: Potency is supported by X-ray crystallography of two leads 161
Carbonic anhydrase activators: X-ray crystallographic and spectroscopic investigations for the interaction of isozymes I and II with histamine. 160
Combined action of a bacterial monooxygenase and a fungal laccase for the biodegradation of mono- and poly-aromatic hydrocarbons. 158
Characterization of the biological conversion of naphthalene to (+)-cis-(1R,2S)-dihydroxy-1,2-dihydronaphthalene in direct micellar systems 155
3D QSAR selectivity analyses of carbonic anhydrase inhibitors: insights for the design of isozyme selective inhibitors. 154
Complexes With Biologically Active Ligands. Part 6 Ni(II) Coordination Compounds of Hydrazine and Heterocyclic Sulfonamides as Inhibitors of the Zinc Enzyme Carbonic Anhydrase. 151
Anion inhibition studies of the fastest carbonic anhydrase (CA) known, the extremo-CA from the bacterium Sulfurihydrogenibium azorense. 151
Carbonic anhydrase activation enhances object recognition memory in mice through phosphorylation of the extracellular signal-regulated kinase in the cortex and the hippocampus. 149
Efficient polycyclic aromatic hydrocarbons dihydroxylation in direct micellar systems 147
Carbonic anhydrase inhibitors. Cloning, characterization and inhibition studies of the cytosolic isozyme III with anions. 147
Salicylate 1,2-dioxygenase from Pseudaminobacter salicylatoxidans: crystal structure of a peculiar ring-cleaving dioxygenase. 146
Antiglaucoma carbonic anhydrase inhibitors: a patent review. 146
Carbonic Anhydrase Inhibitors. Part 55 Metal Complexes of 1,3,4-Thiadiazole-2-Sulfonamide Derivatives: In Vitro Inhibition Studies With Carbonic Anhydrase Isozymes I, II and IV. 145
Crystal structure of the blue multicopper oxidase from the white-rot fungus Trametes trogii complexed with p-toluate 145
7-Substituted-sulfocoumarins are isoform-selective, potent carbonic anhydrase II inhibitors. 145
Carbonic Anhydrase Activators. Part 19 Spectroscopic and Kinetic Investigations for the Interaction of Isozymes I and II With Primary Amines. 144
Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme. 144
Cyclodextrin complexation highly enhances efficacy of arylsulfonylureido benzenesulfonamide carbonic anhydrase inhibitors as a topical antiglaucoma agents 144
Carbonic anhydrase inhibitors: guaiacol and catechol derivatives effectively inhibit certain human carbonic anhydrase isoenzymes (hCA I, II, IX and XII). 142
Plasmonic Particles that Hit Hypoxic Cells 142
ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme 142
Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Treatment of Rheumatoid Arthritis 142
A class of 4-Sulfamoylphenyl-ω-aminoalkyl ethers with effective carbonic anhydrase inhibitory action and antiglaucoma effects. 141
Role of surfactants in optimizing fluorene assimilation and intermediate formation by Rhodococcus rhodochrous VKM B-2469. 141
Carbonic anhydrase inhibitors: inhibition of the cytosolic human isozyme VII with anions. 140
7,8-disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar/subnanomolar range. 140
Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives. 140
Crystallization and preliminary structure analysis of the blue laccase from the ligninolytic fungus Panus tigrinus. 140
H-1 Noe Studies Of Oxidized High-Potential Iron Sulfur Protein-II From Ectothiorhodospira-Halophila 139
Molecular modeling study for the binding of zonisamide and topiramate to the human mitochondrial carbonic anhydrase isoform VA. 139
Unsymmetrical 1,1'-disubstituted ferrocenes: synthesis of Co(ii), Cu(ii), Ni(ii) and Zn(ii) chelates of ferrocenyl -1-thiadiazolo-1'-tetrazole, -1-thiadiazolo-1'-triazole and -1-tetrazolo-1'-triazole with antimicrobial properties. 139
Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides. 139
Phosph(on)ate as a zinc-binding group in metalloenzyme inhibitors: X-ray crystal structure of the antiviral drug foscarnet complexed to human carbonic anhydrase I. 139
Fungal laccase, cellobiose dehydrogenase, and chemical mediators: combined actions for the decolorization of different classes of textile dyes. 138
Complexes with biologically active ligands. Part 11. Synthesis and carbonic anhydrase inhibitory activity of metal complexes of 4,5-disubstituted-3-mercapto-1,2,4-triazole derivatives. 138
Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors. 138
Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides. 138
Structural insights on carbonic anhydrase inhibitory action, isoform selectivity, and potency of sulfonamides and coumarins incorporating arylsulfonylureido groups. 138
X-ray structures of 4-chlorocatechol 1,2-dioxygenase adducts with substituted catechols: New perspectives in the molecular basis of intradiol ring cleaving dioxygenases specificity. 138
Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. 138
Carbonic anhydrase inhibitors: Design of spin-labeled sulfonamides incorporating TEMPO moieties as probes for cytosolic or transmembrane isozymes 137
Carbonic anhydrase inhibitors: inhibition of transmembrane, tumor-associated isozyme IX, and cytosolic isozymes I and II with aliphatic sulfamates. 136
Carbonic anhydrase activators: an activation study of the human mitochondrial isoforms VA and VB with amino acids and amines. 136
Antiobesity carbonic anhydrase inhibitors: a literature and patent review. 136
Complexes with biologically active ligands. Part 9 metal complexes of 5-benzoylamino- and 5-(3-nitrobenzoyl-amino)-1,3,4-thiadiazole-2-sulfonamide as carbonic anhydrase inhibitors. 135
Natural Tannins For Leather Treatments: Biodegradation By Penicillium Chrysogenum Mut 4444 On A Fixed Bed Bioreactor 135
5- and 6-membered (thio)lactones are prodrug type carbonic anhydrase inhibitors. 135
Carbonic anhydrase inhibitors. Part 91. Metal complexes of heterocyclic sulfonamides as potential pharmacological agents in the treatment of gastric Acid secretion imbalances. 135
6-Substituted 1,2-benzoxathiine-2,2-dioxides are isoform-selective inhibitors of human carbonic anhydrases IX, XII and VA. 134
Synthesis of a new series of dithiocarbamates with effective human carbonic anhydrase inhibitory activity and antiglaucoma action 134
Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX. 133
Peptidomimetics as protein arginine deiminase 4 (PAD4) inhibitors. 133
Carbonic Anhydrase Interaction With Lipothioars Enites: A Novel Class of Isozymes I and II Inhibitors. 133
Carbonic anhydrase inhibitors: Inhibition of the new membrane-associated isoform XV with phenols. 133
Carbonic anhydrase activators: activation of the human tumor-associated isozymes IX and XII with amino acids and amines. 133
Carbonic anhydrase catalyzes cyanamide hydration to urea: is it mimicking the physiological reaction? 132
Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue. 132
Crystal structure of 3-chlorocatechol 1,2-dioxygenase key enzyme of a new modified ortho-pathway from the Gram-positive Rhodococcus opacus 1CP grown on 2-chlorophenol. 132
Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose-thioureido tails. 132
Pyridinium derivatives of histamine are potent activators of cytosolic carbonic anhydrase isoforms I, II and VII. 132
Polyamines and α-carbonic anhydrases 132
Nonionic micelles promote whole cell bioconversion of aromatic substrates in an aqueous environment. 132
Direct Micellar Systems as a Tool to Improve the Efficiency of Aromatic Substrate Conversion for Fine Chemicals Production 131
H-1-Nmr Studies On Partially And Fully Reduced 2(4fe-4s) Ferredoxin From Clostridium-Pasteurianum 131
Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides. 129
Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors. 129
Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation. 129
Secondary/tertiary benzenesulfonamides with inhibitory action against the cytosolic human carbonic anhydrase isoforms I and II. 129
Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies. 129
N-hydroxyurea--a versatile zinc binding function in the design of metalloenzyme inhibitors. 129
Carbonic anhydrase activators: activation of isozyme XIII with amino acids and amines. 129
Carbonic anhydrase inhibitors. Synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with boron-containing sulfonamides, sulfamides, and sulfamates: toward agents for boron neutron capture therapy of hypoxic tumors. 129
QSAR studies for the inhibition of the transmembrane carbonic anhydrase isozyme XIV with sulfonamides using PRECLAV software. 128
Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides. 128
The generation of a 1-hydroxy-2-naphthoate 1,2-dioxygenase by single point mutations of salicylate 1,2-dioxygenase – Rational design of mutants and the crystal structures of the A85H and W104Y variants 128
Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides. 128
Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides. 128
Catechol 1,2-dioxygenase from the Gram-positive Rhodococcus opacus 1CP: Quantitative structure/activity relationship and the crystal structures of native enzyme and catechols adducts 128
Totale 15.810
Categoria #
all - tutte 162.591
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 162.591


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.219 0 0 0 0 0 0 1.822 1.942 1.701 725 711 318
2020/20216.853 732 566 619 395 231 864 203 597 682 782 554 628
2021/20224.241 247 446 502 116 169 182 234 256 164 178 623 1.124
2022/20239.115 1.103 1.841 135 674 846 1.739 865 642 801 39 276 154
2023/20242.255 157 401 623 157 141 272 46 264 27 39 71 57
2024/202513.603 711 2.092 1.265 2.380 5.177 1.847 131 0 0 0 0 0
Totale 62.922